These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21567182)

  • 21. Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: results from a multi-center, randomized, double-blind, placebo-controlled trial.
    Ma JF; Wan Q; Hu XY; Sun SG; Wang WZ; Zhao ZX; Wang YJ; Liu CF; Li JM; Jiang YP; Chen SD
    Sleep Med; 2012 Jan; 13(1):58-63. PubMed ID: 22137119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical experience with pramipexole in the treatment of restless legs syndrome.
    Merlino G; Serafini A; Robiony F; Valente M; Gigli GL
    Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):225-35. PubMed ID: 18248314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy, safety and dose-response of pramipexole in Japanese patients with primary restless legs syndrome: randomized trial.
    Inoue Y; Kuroda K; Hirata K; Uchimura N; Kagimura T; Shimizu T
    Neuropsychobiology; 2011; 63(1):35-42. PubMed ID: 21063131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term open-label study of pramipexole in patients with primary restless legs syndrome.
    Inoue Y; Kuroda K; Hirata K; Uchimura N; Kagimura T; Shimizu T
    J Neurol Sci; 2010 Jul; 294(1-2):62-6. PubMed ID: 20451927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term use of pramipexole in the management of restless legs syndrome.
    Lipford MC; Silber MH
    Sleep Med; 2012 Dec; 13(10):1280-5. PubMed ID: 23036265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pramipexole Responsive Neck Numbness: The Therapeutic Role of Dopamine Agonists in the Spinal Cord Indicating to a Common Spinal Pathophysiology with Restless Leg Syndrome (RLS)?
    Yulug B; Hanoglu L
    Curr Clin Pharmacol; 2016; 11(3):221-222. PubMed ID: 27450363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of pregabalin with pramipexole for restless legs syndrome.
    Allen RP; Chen C; Garcia-Borreguero D; Polo O; DuBrava S; Miceli J; Knapp L; Winkelman JW
    N Engl J Med; 2014 Feb; 370(7):621-31. PubMed ID: 24521108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic treatment in idiopathic restless legs syndrome: effects on subjective sleepiness.
    Kallweit U; Khatami R; Pizza F; Mathis J; Bassetti CL
    Clin Neuropharmacol; 2010; 33(6):276-8. PubMed ID: 21060282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.
    Inoue Y; Hirata K; Kuroda K; Fujita M; Shimizu T; Emura N; Uchimura N; Kagimura T; Sha K; Nozawa T
    Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrence of cluster headache with pramipexole.
    Ossemann M
    Acta Neurol Belg; 2010 Sep; 110(3):279-80. PubMed ID: 21114140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pramipexole for the treatment of restless legs syndrome.
    Kushida CA
    Expert Opin Pharmacother; 2006 Mar; 7(4):441-51. PubMed ID: 16503816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.
    Geyer J; Bogan R
    Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pramipexole induced psychosis in a patient with restless legs syndrome.
    Signorelli MS; Battaglia E; Costanzo MC; Cannavò D
    BMJ Case Rep; 2013 Sep; 2013():. PubMed ID: 24049088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restless legs syndrome: differential diagnosis and management with pramipexole.
    Brindani F; Vitetta F; Gemignani F
    Clin Interv Aging; 2009; 4():305-13. PubMed ID: 19750232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis.
    Evans AH; Butzkueven H
    Mov Disord; 2007 Mar; 22(4):590-1. PubMed ID: 17230484
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study.
    Partinen M; Hirvonen K; Jama L; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
    Sleep Med; 2006 Aug; 7(5):407-17. PubMed ID: 16815748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restless legs symptoms in a patient with above knee amputations: a case of phantom restless legs.
    Hanna PA; Kumar S; Walters AS
    Clin Neuropharmacol; 2004; 27(2):87-9. PubMed ID: 15252270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The long-term effects of the dopamine agonist pramipexole in a proposed restless legs syndrome animal model.
    Luo F; Li C; Ondo WG; Xu P; Xie W; Le W
    Sleep Med; 2011 Jan; 12(1):41-6. PubMed ID: 21044864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of pramipexole in restless legs syndrome.
    Kruszewski SP; Shane J
    Neurology; 2007 May; 68(19):1641; author reply 1641-2. PubMed ID: 17485661
    [No Abstract]   [Full Text] [Related]  

  • 40. Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome.
    Quilici S; Abrams KR; Nicolas A; Martin M; Petit C; Lleu PL; Finnern HW
    Sleep Med; 2008 Oct; 9(7):715-26. PubMed ID: 18226947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.